Rejected at 4:18 p.m. May, 05, 2024 ] by Cameron
Author: mohannadkh10
Related Note: 1472091129744 1
Rationale for change

Please reject, but the card is for discussion for a possible change

Rejection reason

Been suggested before, not a needed change; ok for this to be an easy review

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step3_v12::#UWorld::6088 #AK_Step1_v12::#OME::PreClinical::Cardiac::Cardiac_5::Electricity::Arrhythmias #PANCE::EOR::Family_med #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::12_Class_III_Antiarrythmics-Sotalol #AK_Step2_v12::#B&B::02_Cardio::05_Pharm::01_Cardiovascular_Pharmacology_I #AK_Step2_v12::#B&B::02_Cardio::01_Arrhythmias::03_Atrial_Fibrillation_and_Flutter::Extra #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::13_Antiarrhythmics-potassium_channel_blockers_(class_III) #AK_Step2_v12::#SketchyIM::02_ECG_Interpretation_&_Arrhythmias::04_Tachycardia::02_Narrow_Complex_Tachycardia:_Intro_&_pSVT_SOAP #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::04_Antiarrhythmics::03_Class_III #AK_Step2_v12::#SketchyIM::02_ECG_Interpretation_&_Arrhythmias::05_Retired_Lessons::04_Tachycardia::02_Narrow_Complex_Tachycardia_AFib_AFlutter_SOA_MAT_SOAP_[OLD_VERSION] #AK_Step1_v12::#AMBOSS::g5aFjO #AK_Step1_v12::#B&B::06_Cardio::04_Arrhythmias::07_Antiarrhythmic_Drugs_II::Extra #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::13_Class_III_Antiarrhythmics-Ibutilide #AK_Step2_v12::#SketchyIM::02_ECG_Interpretation_&_Arrhythmias::04_Tachycardia::04_Narrow_Complex_Tachycardia:_AFib_&_AFlutter_Management #AK_Step1_v12::#B&B::06_Cardio::04_Arrhythmias::03_Atrial_Fibrillation_and_Flutter::Extra #AK_Step1_v12::#Bootcamp::Cardiology::14_Atrial_Arrhythmias::02_Atrial_Flutter #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::19_Class_III_Antiarrhythmics #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::11_Class_III_Antiarrhythmics-Amiodarone #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::05_Antiarrhythmic_Drugs #PANCE::CARDIO::conduction_disorders/dysrhythmias #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::08_Class_III_Amiodarone #AK_Step3_v12::#OME::Intern_Content::Common_Medical_Problems::AFib #AK_Step1_v12::#B&B::06_Cardio::04_Arrhythmias::06_Antiarrhythmic_Drugs_I::Extra #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Bootcamp::Cardiology::14_Atrial_Arrhythmias::01_Atrial_Fibrillation #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::07_Class_III_Sotalol #AK_Step1_v12::#AMBOSS::bOaHIk #AK_Step1_v12::#Bootcamp::Cardiology::13_Antiarrhythmics::04_Class_III_Antiarrhythmics #PANCE::EOR::IM #AK_Step1_v12::^Systems::Cardio::Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::02_Dofetilide_&_Ibutilide